Effects of bortezomib on HIF-1 and HIF-2 transcriptional activities
Bortezomib is the first proteasomal inhibitor (PI) to be used therapeutically in humans for treating relapse cases of multiple myeloma and mantle cell lymphoma. A proposed mechanism is that it prevents proteasomal degradation of pro-apoptotic proteins, leading to enhance apoptosis. Although the alp...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2013
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/48690/1/FBSB%202013%2039R.pdf http://psasir.upm.edu.my/id/eprint/48690/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|